Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 3 | Y015995 | OT |
patient they had recently vaccinated with MMR II tested positive for measles.; This spontaneous report was received from a Physician and refers to currently 1-year old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 29-APR-2025, the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Injection, lot #Y015995, expiration date was not reported, but upon internal validation was established as 24-SEP-2026, diluted with sterile diluent (MERCK STERILE DILUENT) (Lot #, expiration date, dose, frequency were not reported) administered subcutaneously for Prophylaxis. In 2025, the patient presented symptoms like rash, cough and high fever. The patient was seen in an emergency room and tested positive for measles. The patient was not admitted to the hospital. At the reporting time, the outcome event was unknown. An epidemiologist reported that was the third case reported from this lot number. The causal relationship between the event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was unknown. This is one of several cases from the same reporter.; Reporter's Comments: Keywords : MUL
sterile diluent
Test Date: 2025; Test Name: MMR Test; Result Unstructured Data: Positive